Evidence map›Paper›PMID 33276377›Full record

ArticleHuman molecular genetics2020

Heterozygous loss of WBP11 function causes multiple congenital defects in humans and mice.

Ella M M A Martin, Annabelle Enriquez, Duncan B Sparrow, David T Humphreys, Aideen M McInerney-Leo, Paul J Leo, Emma L Duncan, Kavitha R Iyer, Joelene A Greasby, Eddie Ip and 24 more

Open access · greenAbstract read
In one paragraph

Article in Human molecular genetics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Timing of NAD Deficiency During Organogenesis Dictates Defect Type and Penetrance.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. High-impact rare genetic variants in severe schizophrenia.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  15. Review
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

34 authors at 16 institutions in 7 countries.

Ella M M A MartinDevelopment & Stem Cell Biology Division, Victor Chang Cardiac Research Institute, Sydney 2010, Australia.
Annabelle EnriquezDevelopment & Stem Cell Biology Division, Victor Chang Cardiac Research Institute, Sydney 2010, Australia.
Duncan B SparrowDevelopment & Stem Cell Biology Division, Victor Chang Cardiac Research Institute, Sydney 2010, Australia.
David T HumphreysFaculty of Medicine, UNSW, Sydney 2052, Australia.
Aideen M McInerney-LeoDermatology Research Centre, The University of Queensland Diamantina Institute, Translational Research Institute, Brisbane 4072, Australia.
Paul J LeoTranslational Genomics Group, Institute of Health and Biomedical Innovation, Queensland University of Technology, Translational Research Institute, Princess Alexandra Hospital, Woolloongabba 4102, Australia.
Emma L DuncanTranslational Genomics Group, Institute of Health and Biomedical Innovation, Queensland University of Technology, Translational Research Institute, Princess Alexandra Hospital, Woolloongabba 4102, Australia.
Kavitha R IyerDevelopment & Stem Cell Biology Division, Victor Chang Cardiac Research Institute, Sydney 2010, Australia.
Joelene A GreasbyDevelopment & Stem Cell Biology Division, Victor Chang Cardiac Research Institute, Sydney 2010, Australia.
Eddie IpFaculty of Medicine, UNSW, Sydney 2052, Australia.
Eleni GiannoulatouFaculty of Medicine, UNSW, Sydney 2052, Australia.
Delicia ShengDevelopment & Stem Cell Biology Division, Victor Chang Cardiac Research Institute, Sydney 2010, Australia.
Elizabeth WohlerMcKusick-Nathans Department of Genetic Medicine, Johns Hopkins University, Baltimore 21287, USA.
Clémantine DimartinoLaboratory of Embryology and Genetics of Human Malformations, Institute National de la Santé et de la Recherche Médicale (INSERM) UMR 1163, Institut Imagine, Paris 75015, France.
Jeanne AmielLaboratory of Embryology and Genetics of Human Malformations, Institute National de la Santé et de la Recherche Médicale (INSERM) UMR 1163, Institut Imagine, Paris 75015, France.
Yline CapriDépartement de Génétique, Hôpital Robert Debré, Assistance Publique Hôpitaux de Paris, Paris 75019, France.
Daphné LehalleCentre Hospitalier Intercommunal Créteil, Créteil 94000, France.
Adi MoryThe Genetics Institute, Tel Aviv Sourasky Medical Center, Tel Aviv 6423906, Israel.
Yael WilnaiThe Genetics Institute, Tel Aviv Sourasky Medical Center, Tel Aviv 6423906, Israel.
Yael LebenthalSackler Faculty of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel.
Ali G GharaviDepartment of Medicine, Division of Nephrology, Columbia University, New York, NY 10032, USA.
Grażyna G KrzemieńDepartment of Pediatrics and Nephrology, Warsaw Medical University, Warsaw 02-091, Poland.
Monika MiklaszewskaDepartment of Pediatric Nephrology and Hypertension, Jagiellonian University Medical College, Kraków 30-663, Poland.
Robert D SteinerMarshfield Clinic Health System, Marshfield, WI 54449, USA.
Cathy RaggioHospital for Special Surgery, Pediatrics Orthopedic Surgery, New York, NY 10021, USA.
Robert BlankDepartment of Medicine, Medical College of Wisconsin, Milwaukee, WI 53226, USA.
Hagit Baris FeldmanThe Genetics Institute, Tel Aviv Sourasky Medical Center, Tel Aviv 6423906, Israel.
Hila Milo RasoulyDepartment of Medicine, Division of Nephrology, Columbia University, New York, NY 10032, USA.
Nara L M SobreiraMcKusick-Nathans Department of Genetic Medicine, Johns Hopkins University, Baltimore 21287, USA.
Rebekah JoblingDivision of Clinical and Metabolic Genetics, The Hospital for Sick Children, Toronto, ON M5G1X3, Canada.
Christopher T GordonLaboratory of Embryology and Genetics of Human Malformations, Institute National de la Santé et de la Recherche Médicale (INSERM) UMR 1163, Institut Imagine, Paris 75015, France.
Philip F GiampietroDepartment of Pediatrics, University of Illinois-Chicago, Chicago, IL 60607, USA.
Sally L DunwoodieDevelopment & Stem Cell Biology Division, Victor Chang Cardiac Research Institute, Sydney 2010, Australia.
Gavin ChapmanDevelopment & Stem Cell Biology Division, Victor Chang Cardiac Research Institute, Sydney 2010, Australia.
Victor Chang Cardiac Research Institute · AUDélégation Paris 5 · FRTranslational Research Institute · AUColumbia University · USJohns Hopkins University · USTel Aviv Sourasky Medical Center · ILTel Aviv University · ILAssistance Publique – Hôpitaux de Paris · FRHôpital Intercommunal de Créteil · FRHospital for Sick Children · CAHospital for Special Surgery · USJagiellonian University · PLMedical College of Wisconsin · USMedical University of Warsaw · PLUniversity of Illinois Chicago · USUniversity of Wisconsin–Madison · US

Funding

Baylor-Johns Hopkins Center for Mendelian GeneticsUM1HG006542 · NHGRI · JOHNS HOPKINS UNIVERSITY · PI VALLE, DAVID · 2016 to 2020
$14.5M
Sleep and Circadian Dysfunction, Brain and Neurobehavioral Development in AutismP50HD103538 · NICHD · HUGO W. MOSER RES INST KENNEDY KRIEGER · PI S. Ali Fatemi, Bradley L Schlaggar · 2020 to 2026
$9.9M
Genetics of Renal HypodyslasiaR01DK080099 · NIDDK · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI GHARAVI, ALI G · 2008 to 2023
$6.3M
Functional Analysis of Whole Exome Sequence Variants Identified in Patients with Vertebral MalformationsR03HD099516 · NICHD · UNIVERSITY OF ILLINOIS AT CHICAGO · PI GIAMPIETRO, PHILIP F · 2020 to 2021
$247k
NHGRI NIH HHS UM1 HG006542NICHD NIH HHS P50 HD103538NICHD NIH HHS R03 HD099516NIDDK NIH HHS R01 DK080099
6 · The paper itself

Abstract

The genetic causes of multiple congenital anomalies are incompletely understood. Here, we report novel heterozygous predicted loss-of-function (LoF) and predicted damaging missense variants in the WW domain binding protein 11 (WBP11) gene in seven unrelated families with a variety of overlapping congenital malformations, including cardiac, vertebral, tracheo-esophageal, renal and limb defects. WBP11 encodes a component of the spliceosome with the ability to activate pre-messenger RNA splicing. We generated a Wbp11 null allele in mouse using CRISPR-Cas9 targeting. Wbp11 homozygous null embryos die prior to E8.5, indicating that Wbp11 is essential for development. Fewer Wbp11 heterozygous null mice are found than expected due to embryonic and postnatal death. Importantly, Wbp11 heterozygous null mice are small and exhibit defects in axial skeleton, kidneys and esophagus, similar to the affected individuals, supporting the role of WBP11 haploinsufficiency in the development of congenital malformations in humans. LoF WBP11 variants should be considered as a possible cause of VACTERL association as well as isolated Klippel-Feil syndrome, renal agenesis or esophageal atresia.

Indexed as

Abnormalities, MultipleAnal CanalAnimalsDNA-Binding ProteinsEsophagusHaploinsufficiencyHeart Defects, CongenitalHeterozygoteHumansKidneyLimb Deformities, CongenitalLoss of Function MutationMiceRNA SplicingRNA Splicing FactorsSpineDNA-Binding ProteinsRNA Splicing FactorsWBP11 protein, human

Identifiers

PMID33276377
PMCPMC7823106
OpenAlexW3109555147

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.